 |
Витамин D и депрессия. Гинкго билоба. Гюперзин A. Мелатонин. Фосфатидилсерин. Винпоцетин
|
|
|
|
Витамин D и депрессия
Armstrong, D. J., G. K. Meenagh, I. Bickle, et al. 2007. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clinical Rheumatology 26(4): 551–554.
Berk, M., K. M. Sanders, J. A. Pasco, et al. 2007. Vitamin D deficiency may play a role in depression. Medical Hypotheses 69(6): 1316–1319.
Wilkins, C. H., Y. I. Sheline, C. M. Roe, et al. 2006. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. American Journal of Geriatric Psychiatry 14(12): 1032–1040.
Глава 8
Гинкго билоба
Burns, N., J. Bryan, and T. Nettelbeck. 2006. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Human Psychopharmacology 21(1): 27–37.
Dodge, H., T. Zitzelberger, B. Oken, et al. 2008. A randomized placebo– controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70(19): 1809–1817.
Hartley, D., L. Heinze, S. Elsabagh, et al. 2003. Effects on cognition and mood in postmenopausal women of 1– week treatment with Ginkgo biloba. Pharmacology Biochemistry and Behavior 75(3): 711–720.
Le Bars, P. L. 2003. Response patterns of EGb 761 in Alzheimer’s disease: influence of neuropsychological profiles. Pharmacopsychiatry 36(Suppl. 1): S50–55.
Le Bars, P. L., and J. Kastelan. 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutrition 3(4A): 495–499.
Mix, J., and W. Crews. 2002. A double– blind, placebo– controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings. Human Psychopharmacology 17(6): 267–277.
Nathan, P., S. Tanner, J. Lloyd, et al. 2004. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans. Human Psychopharmacology 19(2): 91–96.
Singh, B., H. Song, X. Liu, et al. 2004. Dangshen (Codonopsis pilosula) and Bai guo (Ginkgo biloba) enhance learning and memory. Alternative Therapies in Health & Medicine 10(4): 52–56.
Гюперзин A
Aisen, P. 2007. A multi– center, double– blind, placebo– controlled therapeutic trial to determine whether natural huperzine A improves cognitive function. Clinical Trials.
Ved, H., M. Koenig, J. Dave, et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8(4): 963–967.
Xu, S., Z. Cai, Z. Qu, et al. 1999. Huperzine– A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 20(6): 486–490.
Zhang, R., X. Tang, Y. Han, et al. 1991. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 12(3): 250–252.
Мелатонин
Almeida Montes, L. G., M. P. Ontiveros Uribe, S. J. Cortes, et al. 2003. Treatment of primary insomnia with melatonin: A double– blind, placebo– controlled, crossover study. Journal of Psychiatry & Neuroscience 28(3): 191–196.
|
|
|
Cardinali, D. P., E. Gvozdenovich, and M. R. Kaplan. 2002. A double‑ blind placebo‑ controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuroendocrinology Letters 23(1): 55–60.
Dowling, G. A., R. L. Burr, E. J. Van Someren, et al. 2008. Melatonin and brightlight treatment for rest– activity disruption in institutionalized patients with Alzheimer’s disease. Journal of the American Geriatrics Society 56(2): 239–246.
Pillar, G., E. Shahar, N. Peled, et al. 2000. Melatonin improves sleep– wake patterns in psychomotor retarded children. Pediatric Neurology 23(3): 225–228.
Smits, M. G., E. E. Nagtegaal, H. J. van der, et al. 2001. Melatonin for chronic sleep onset insomnia in children: A randomized placebo– controlled trial. Journal of Child Neurology 16(2): 86–92.
Фосфатидилсерин
Crook, T., W. Petrie, C. Wells, et al. 1992. Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacology Bulletin 28: 61–66.
Hellhammer, J., E. Fries, C. Buss, et al. 2004. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 7: 119–126.
Jorissen, B. L., F. Brouns, M. P. Van Boxtel, et al. 2001. The influence of soy– derived phosphatidylserine on cognition in age– associated memory impairment. Nutritional Neuroscience 4: 121–134.
Palmieri, G., R. Palmieri, M. R. Inzoli, et al. 1987. Double– blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clinical Trials 24: 73–83.
Винпоцетин
Balestreri, R., L. Fontana, and F. Astengo. 1987. A double– blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. Journal of the American Geriatrics Society 35(5): 425–430.
Bereczki, D., and I. Fekete. 1999. A systematic review of vinpocetine therapy in acute ischaemic stroke. European Journal of Clinical Pharmacology 55(5): 349–352.
Gulyas, B., C. Halldin, P. Karlsson, et al. 1999. Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies. [in Hungarian]. Orvusi Hetilap 140(30): 1687–1691.
Vas, A., B. Gulyas, Z. Szabo, et al. 2002. Clinical and non– clinical investigations using positron emission tomography, near infrared spectroscopy and trans ‑ cranial Doppler methods on the neuroprotective drug vinpocetine: A summary of evidences. Journal of Neurological Science 203–204: 259–262.
Глава 9
Aron, A., H. Fisher, D. J., et al. 2005. Reward, motivation, and emotion systems associated with early– stage intense romantic love. Journal of Neurophysiology 94(1): 327–337.
Fisher, H., A. Aron, and L. L. Brown. 2005. Romantic love: An fMRI study of a neural mechanism for mate choice. Journal of Comparative Neurology 493(1): 58–62.
Fisher, H. E., A. Aron, D. Mashek, et al. 2002. Defining the brain systems of lust, romantic attraction, and attachment. Archives of Sexual Behavior 31(5): 413–419.
|
|
|
Volkow, N. D., G. J. Wang, J. S. Fowler, et al. 1999. Association of methylphenidateinduced craving with changes in right striato– orbitofrontal metabolism in cocaine abusers: Implications in addiction. American Journal of Psychiatry 156(1): 19–26.
|
|
|
